Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Rheumatology

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 14677189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcription.

  2002cited by this paper
• Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic rats.

  2001cited by this paper
• The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon

  2001cited by this paper
• Nitric oxide and T helper cell immunity.

  2001cited by this paper
• Cytotoxicity associated with induction of nitric oxide synthase in rat duodenal epithelial cells in vivo by lipopolysaccharide of Helicobacter pylori: inhibition by superoxide dismutase

  2000cited by this paper
• Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker

  2000cited by this paper
• Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production.

  1999cited by this paper
• Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.

  1999cited by this paper
• Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines

  1998cited by this paper
• Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease

  1998cited by this paper
• Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.

  1998cited by this paper
• Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis

  1998cited by this paper
• Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment.

  1998cited by this paper
• Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats.

  1997cited by this paper
• Distribution of inducible nitric oxide synthase in ulcerative colitis.

  1997cited by this paper
• Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation.

  1997cited by this paper
• Increased Nitric Oxide Production and Inducible Nitric Oxide Synthase Activity in Colonic Mucosa of Patients with Active Ulcerative Colitis and Crohn's Disease

  1997cited by this paper
• Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease.

  1996cited by this paper
• Expression of nitric oxide synthase in ulcerative colitis

  1996cited by this paper
• Long-term evolution of gut inflammation in patients with spondyloarthropathy.

  1996cited by this paper
• Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.

  1995cited by this paper
• Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity.

  1994cited by this paper
• Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge.

  1994cited by this paper
• Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies

  1994cited by this paper
• High frequency of silent inflammatory bowel disease in spondylarthropathy.

  1994cited by this paper
• Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

  1993cited by this paper
• The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat

  1993cited by this paper
• Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

  1993cited by this paper
• Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

  1992cited by this paper
• Spondylarthropathy and gut inflammation: immunopathogenetic mechanisms.

  1992cited by this paper
• Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy.

  1992cited by this paper
• Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.

  1991cited by this paper
• Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.

  1991cited by this paper
• Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases

  1991cited by this paper
• Intestinal permeability in ankylosing spondylitis.

  1990cited by this paper
• Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies.

  1990cited by this paper
• Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation.

  1990cited by this paper
• Ileocolonoscopy in seronegative spondylarthropathy.

  1989cited by this paper
• Systematic ileocolonoscopy and bowel biopsy study in spondylarthropathy.

  1987cited by this paper
• Histopathology of intestinal inflammation related to reactive arthritis.

  1987cited by this paper
• Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

  1987cited by this paper
• HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.

  1985cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper

• Effect of supplementation with yeast polysaccharides on intestinal function in piglets infected with porcine epidemic diarrhea virus

  2024cites this paper
• Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA

  2023cites this paper
• AGGRESSIVE AND PROTECTIVE MEDIATORS IN THE REGULATION OF INTESTINAL MUCOSAL INTEGRITY

  2019cites this paper
• Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?

  2017cites this paper
• The Biology of Spondyloarthritis: Studies of the host immune response in experimental Chlamydia infection and in patients with ankylosing spondylitis

  2016cites this paper
• Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis.

  2016cites this paper
• Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis.

  2016cites this paper
• Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis.

  2014cites this paper
• The immunopathogenesis of ankylosing spondylitis

  2013cites this paper
• Rs4676410 and Rs2531875 are Associated with the Risk of Ankylosing Spondylitis in the Han Chinese Population

  2013cites this paper
• Microbiote intestinal et spondylarthrites: quelles perspectives ?

  2011cites this paper
• The benefits & potential health hazards posed by the prebiotic inulin - a review.

  2010cites this paper
• iNOS Expression in Oral and Gastrointestinal Tract Mucosa

  2008cites this paper
• Factors Involved in Upregulation of Inducible Nitric Oxide Synthase in Rat Small Intestine Following Administration of Nonsteroidal Anti-inflammatory Drugs

  2006cites this paper
• Animal models of HLA-B27-associated diseases: new outcomes.

  2006cites this paper
• Modles animaux de spondylarthropathies lis au HLA-B27 : o en est la recherche?

  2006cites this paper
• Nitric oxide-modulating agents for gastrointestinal disorders

  2005cites this paper
• [Not Available].

  2005cites this paper
• [Extra-articular manifestations and complications of ankylosing spondylitis].

  2005cites this paper
• Estrategias terapéuticas en las manifestaciones extraarticulares de la espondiloartritis anquilosante

  2005cites this paper
• Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.

  2004cites this paper
• Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.

  2004cites this paper
• Darmerkrankungen und Arthropathie

  2004cites this paper
• The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface.

  2003cites this paper
• New dogmas or old?

  2003cites this paper